ABSTRACT
Background Physical activity (PA), aerobic fitness, and cardiometabolic diseases (CMD) are highly heritable multifactorial phenotypes. Shared genetic factors may underlie the associations between higher levels of PA and better aerobic fitness and a lower risk for cardiometabolic CMDs. Our aim was first to validate PA genotype against self-reported leisure-time PA (LTPA) and second to study how PA genotype associates with aerobic fitness and CMD risk factors. Finally, we investigated if PA genotype predicts CMD endpoints. We expected that these analyses would provide evidence for pleiotropic effects (same gene variants explaining both phenotypes) of PA and CMDs.
Methods and findings Polygenic risk score (PRS) for PA was constructed in the Trøndelag Health Study (N=47,148) using UK Biobank single nucleotide polymorphism-specific weights (N=400,124). The results showed that genotypes predisposing to higher PA were associated with greater self-reported PA (Beta [B]=0.282 MET-h·wk-1 per SD of PRS for PA, 95% confidence interval [CI]=0.211, 0.354) but not with aerobic fitness. These genotypes were also associated with healthier profile in CMD risk factors (waist circumference [B=-0.003 cm, 95% CI=-0.004, -0.002], body mass index [B=-0.002 kg·(m2)-1, 95% CI=-0.004, -0.001], high-density lipoprotein cholesterol [B=0.004 mmol·L-1, 95% CI=0.002, 0.006]) and lower incidence of hypertensive diseases (HR=0.97, 95% CI=0.951, 0.990), stroke (HR=0.94, 95% CI=0.903, 0.978) and type 2 diabetes (HR=0.94, 95% CI=0.902, 0.970). When accounting for self-reported PA, the associations between PA genotypes and CMD risk factors remained statistically significant.
Conclusions Genotypes predisposing to higher PA were associated with higher amount of PA. However, in general the predictive value of the PRS for PA in predicting self-reported PA was low, possibly because of the acknowledged inconsistencies in assessing PA in cohort studies. Genotypes predisposing to higher PA were also associated with better cardiometabolic health and lower incidence of CMDs, and the observed associations were independent of self-reported PA. These results support earlier findings suggesting small pleiotropic effects between PA and CMDs and provide new evidence about associations with polygenic inheritance of PA and intermediate CMD risk factors. The observed association were however small, and results do not suggest clinical relevance in health promotion.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GenActive study is funded by the Academy of Finland (341750, 346509 to E.S.), Juho Vainio Foundation (E.S.) and Päivikki and Sakari Sohlberg foundation (E.S.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North West Multi-Centre Research Ethics Committee approved the UK Biobank study (approval number: 11/ NW/0382). HUNT3 was approved by the Regional Committee for Medical and Health Research Ethics (no. 29771). HUNT Study was approved by the Norwegian Data Inspectorate, and by the National Directorate of Health.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The summary statistics for the self-reported MPA GWAS are available from the Pan-UKBB phenotype manifest web page. The used HUNT Study datasets are available under restricted access by application to HUNT Databank.
